Factors related to the absence of anemia in hemodialysis patients

Blood Purification

Volumn 32, Issue 1, 2011, Pages 69-74

  Verdalles, Ursula ^a   Abad, Soraya ^a   Vega, Almudena ^a   Ruiz Caro, Caridad ^a   Ampuero, Jara ^a   Jofre, Rosa ^a   Lopez Gomez, Juan Manuel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Adult polycystic kidney disease; Anemia; Endogenous erythropoietin; Erythropoiesis stimulating agents; HCV liver disease; Hemodialysis; Renal replacement therapy

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C VIRUS; HUMAN; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; LIVER CYST; LIVER DISEASE; MALE; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TREATMENT DURATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; CYSTS; ERYTHROPOIETIN; FEMALE; HEMATINICS; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREVALENCE; PROSPECTIVE STUDIES; RENAL DIALYSIS; SPLEEN;

EID: 79951850679     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000323095     Document Type: Article

References (30)

1. Ishikawa I: Acquired cystic disease: mechanisms and manifestations. Semin Nephrol 1991; 11: 671-684.
2. Anderson ET, Walker BR: Polycystic kidney disease, polycythemia and azotemia. JAMA 1969; 208: 2472-2473.
3. Martt JM, Sayman A, Neal MP: Polycythemia and hydronephrosis. Ann Intern Med 1961; 54: 790-795.
4. Tarazi R, Frolich ED, Dutsan HP, Gifford RW Jr, Page IH: Hypertension and high hematocrit: another clue to renal arterial disease. Am J Cardiol 1966; 18: 855-858.
5. Kazal LA, Erslev AJ: Erythropoietin production in renal tumors. Ann Clin Lab Sci 1975; 5: 98-105.
6. Charfeddine K, Zaghdane S, Yaich S, Hakim A, Hachicha J: Factors predisposing to postrenal transplant erythrocytosis: a retrospective study. Saudi J Kidney Dis Transpl 2008; 19: 371-377.
7. Gordon AS, Zanjani ED, Zalusky R: A possible mechanism for the erythropoiesis associated with hepatocellular carcinoma in man. Blood 1970; 35: 151-157.
8. Kolk-Vegter AJ, Bosch E, van Leeuwen AM: Influence of serum hepatitis on haemoglobin level in patients on regular haemodialysis. Lancet 1971;i:526-528.
9. Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, Greenwood R, Feldman HI, Port FK, Held PJ: Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 121-132. (Pubitemid 38072623)
10. Cohen NN: Polycythemia associated with bilateral unilocular renal cysts. Arch Intern Med 1960; 105: 301-304.
11. Feustel A, Bellmann H, Hefftler U: Renal polycythemia as a facultative leading symptom in kidney tumors, hydronephrosis ad cystic kidney. Urol Nephrol 1970; 63: 705-714.
12. Eckardt KU, Drueke T, Leski M, Kurtz A: Unutilized reserves: the production capacity for erythropoietin appears to be conserved in chronic renal disease. Contrib Nephrol. Basel. Karger, 1991, vol 88, pp 18-31.
13. Fick GM, Gabow PA: Hereditary and acquired cystic disease of the kidney. Kidney Int 1994; 46: 951-964. (Pubitemid 24319931)
14. Edmunds ME, Devoy M, Tomson CRV, Krishna U, Clayworth A, Durrant STS, Feehally J, Walls J: Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment. Br J Haematol 1991; 78: 275-277.
15. Khurana A, Níkel A, Narayanan M, Foulks C: Effect of hepatitis C infection on anemia in hemodialysis patients. Hemodial Int 2008; 12: 94-99. (Pubitemid 351247385)
16. Simon P, Meyrier A, Tanquerel T, Ang KS: Improvement of anaemia in haemodialysed patients alter viral or toxic hepatic cytolysis. Br Med J 1980; 29: 892-894. (Pubitemid 10105563)
17. Shih LY, Huang JY, Lee Ct: Insulin like growth factor I plays a role in regulating erythropoiesis in patients with end-stage renal disease and erythrocytosis. J Am Soc Nephrol 1999; 10: 315-322.
18. Nelson SM, Freeman DJ, Sattar N, Lindsay RS: Erythrocytosis in offspring of mothers with type 1 diabetes-are factors other than insulin critical determinants? Diabet Med 2009; 26: 887-892.
19. Bravo P, Felgueiras J, Santos C, Oliveira C, Ponce P: Angiotensin-converting enzyme inhibitors after renal transplantation. Transplant Proc 2008; 40: 740-742. (Pubitemid 351608684)
20. Solbu MD, Jenssen TG, Eriksen BO, Toft I: Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension - the impact of microalbuminuria: a 13-year follow-up study. Metabolism 2009; 58: 408-415.
21. Guarnieri G, Zanetti M, Vinci P, Cattin MR, Barazzoni R: Insulin resistance in chronic uremia. J Ren Nutr 2009; 19: 20-24.
22. Kato H, Ishida J, Imagawa S, Saito T, Suzuki N, Matsuoka T, Sugaya T, Tanimoto K, Yokoo T, Ohneda O, Sugiyama F, Yagami K, Fujita T, Yamamoto M, Nangaku M, Fukamizu A: Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor. FASEB 2005; 19: 2023-2035.
23. Vlahakos DV, Marathias KP, Agroyannis B, Madias NE: Post-transplant erythrocytosis. Kidney Int 2003; 4: 1187-1194.
24. Kiberd BA: Post-transplant erythrocytosis: a disappearing phenomenon? Clin Transplant 2008: 10: 1399-1412.
25. Cruzado JM, Rico J, Grinyó JM: The reninangiotensin system blockade in kidney transplantation: pros and cons. Transpl Int 2008; 21: 304-313. (Pubitemid 351348021)
26. Ishizaki M, Terasawa Y: Cystic diseases of the kidney in end-stage renal diseases with long-term hemodialysis. Nippon Rinsho 1992; 50: 842-847.
27. Barton IK, Mansell MA: Erythrocytosis induced by danazol in an anephric patient. Br Med J (Clin Res Ed) 1987; 7: 294-300.
28. Lopez-Gomez JM, Portolés JM, Aljama P, on behalf of the MAR Study Group: Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int 2008; 11: 575-581.
29. Meyrier A, Simon P, Boffa G, Brissot P: Uremia and the liver. 1. The liver and erythropoiesis in chronic renal failure. Nephron 1981; 29: 3-6. (Pubitemid 12241804)
30. Navarro JF, Mora C, Macía M, García J: Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Kidney Int 2002; 61: 1537-1544. (Pubitemid 34304516)